Ciprofloxacin For Reactive Arthritis Has No Advantage Over Placebo – (08-25-00)



Ciprofloxacin For Reactive Arthritis Has No Advantage Over Placebo

Although it is well known that certain gastrointestinal infections can cause a reactive arthritis, this study suggests that long term strong antibiotics do not help with symptoms. Unfortunately, these researchers have missed the evidence that suggests that it is not the infectious agent itself that causes the problems, but rather the environment set up by the presence of the infection. Adding strong antibiotics will just kill off more of the normal flora that’s supposed to be there, and evidence suggests that this flora may protect our bodies from the environment.

Ann Rheum Dis 2000;59:565-570 Treatment of reactive arthritis with a 3-month course of ciprofloxacin is no more beneficial than placebo, according to study results published in the July issue of Annals of the Rheumatic Diseases. Antibiotic treatment of reactive arthritis is controversial, the investigators note. “Eradication of the causative microbe appears logical,” but previous studies have shown that “short-term antibiotic treatment has no beneficial effect on the outcome of reactive arthritis,” they write.

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Arthritis
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”